Mylan launching cheaper generic EpiPen in wake of outcry over price hike
Mylan says it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine.
The company said Monday that its U.S. subsidiary will put out a generic version of the EpiPen that will have a list price of $300 for a two-pack — about half the current price. It will be available in both 0.15 mg and 0.30 mg strengths.
EpiPens are used in emergencies to treat severe allergies to insect bites and foods like nuts and eggs that can lead to anaphylactic shock.
People usually keep a number of EpiPens handy at home, school or work. The syringes, prefilled with the hormone epinephrine, expire after a year.
Mylan N.V. said that it anticipates having the generic versions available in the next several weeks. It will continue to market and distribute a branded EpiPen.
The company charges $608 for a two-pack of the branded EpiPen. Mylan said it will keep in place the $300 savings card for the branded EpiPen and the revised patient assistance program announced last week.
Consumers and politicians have accused the company of price-gouging, considering that the product has been on the market since 1987 and the price didn’t start rising significantly until Mylan acquired it in 2007.
There is also little competition, with the only rival product being Adrenaclick, which carries a list price of $461.
Read more at Chicago Tribune
Trending Now on Survival Nation
Sorry. No data so far.